NCT01369160View on ClinicalTrials.gov

Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

March 31, 2014

Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL

Quality of Life measures

measuring QOL with different therapies

Trial Locations (2)

30322

Children's Healthcare of Atlanta/Emory University, Atlanta

Children's Healthcare of Atlanta, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT01369160 - Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease | Biotech Hunter | Biotech Hunter